183 related articles for article (PubMed ID: 16948217)
1. [Pathophysiology of multiple sclerosis].
Smith KJ
Rev Prat; 2006 Jun; 56(12):1299-303. PubMed ID: 16948217
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.
Smith KJ; McDonald WI
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1649-73. PubMed ID: 10603618
[TBL] [Abstract][Full Text] [Related]
3. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
5. Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
Davis SL; Frohman TC; Crandall CG; Brown MJ; Mills DA; Kramer PD; Stüve O; Frohman EM
Neurology; 2008 Mar; 70(13 Pt 2):1098-106. PubMed ID: 18287569
[TBL] [Abstract][Full Text] [Related]
6. Axonal transection in the lesions of multiple sclerosis.
Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L
N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407
[TBL] [Abstract][Full Text] [Related]
7. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
Andrews HE; Nichols PP; Bates D; Turnbull DM
Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis and basis for treatment in multiple sclerosis.
Compston A
Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
[TBL] [Abstract][Full Text] [Related]
10. Sodium channels as molecular targets in multiple sclerosis.
Waxman SG
J Rehabil Res Dev; 2002; 39(2):233-42. PubMed ID: 12051467
[TBL] [Abstract][Full Text] [Related]
11. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
De Keyser J; Steen C; Mostert JP; Koch MW
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
[TBL] [Abstract][Full Text] [Related]
12. Protecting axons in multiple sclerosis.
Wilkins A; Scolding N
Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
14. Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders.
Smith KJ
Eye (Lond); 1994; 8 ( Pt 2)():224-37. PubMed ID: 7958027
[TBL] [Abstract][Full Text] [Related]
15. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
De Keyser J; Zeinstra E; Mostert J; Wilczak N
Trends Pharmacol Sci; 2004 Feb; 25(2):67-71. PubMed ID: 15102491
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial changes associated with demyelination: consequences for axonal integrity.
Campbell GR; Mahad DJ
Mitochondrion; 2012 Mar; 12(2):173-9. PubMed ID: 21406249
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in multiple sclerosis: mechanisms and management.
Vucic S; Burke D; Kiernan MC
Clin Neurophysiol; 2010 Jun; 121(6):809-17. PubMed ID: 20100665
[TBL] [Abstract][Full Text] [Related]
18. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
19. Physiopathology of symptoms and signs in multiple sclerosis.
Sá MJ
Arq Neuropsiquiatr; 2012 Sep; 70(9):733-40. PubMed ID: 22990733
[TBL] [Abstract][Full Text] [Related]
20. Remyelination protects axons from demyelination-associated axon degeneration.
Irvine KA; Blakemore WF
Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
